When the Pandemic Ends and the Endemic Continues: The Evolving Role of Monoclonal Antibody Therapies in the Fight Against COVID-19-Live Webinar

This live webinar will explore the role of monoclonal antibody treatments and their effectiveness for high-risk patients with COVID-19. Led by Michael Anderson, MD, MBA, Senior Advisor at the HHS Office of the Assistant Secretary for Preparedness and Response in Washington, D.C., the webinar will provide an up-to-the minute review on these expanding therapies and the role they will continue to play as the COVID-19 pandemic shifts to a national epidemic.


Learning Objectives


At the conclusion of this activity, participants should be able to: 

  • Recognize the role that monoclonal therapies play and the critical treatment timing window
  • Differentiate among the available therapies based on EUA data
  • Work collaboratively across the healthcare continuum of care to help ensure all appropriate patients can have access to the therapies, including those therapies secured by the federal government
  • Appreciate the need to identify patients at greatest risk, particularly those in underserved communities or minority groups